1. Home
  2. NMTC

as of 02-06-2026 12:53pm EST

$0.78
+$0.05
+6.12%
Stocks Health Care Medical/Dental Instruments Nasdaq

NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.

Founded: 2009 Country:
United States
United States
Employees: N/A City: EDEN PRAIRIE
Market Cap: 43.4M IPO Year: N/A
Target Price: $2.23 AVG Volume (30 days): 266.1K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.09 EPS Growth: N/A
52 Week Low/High: $0.40 - $1.25 Next Earning Date: 02-12-2026
Revenue: $12,097,692 Revenue Growth: 250.35%
Revenue Growth (this year): -5.09% Revenue Growth (next year): 32.08%
P/E Ratio: N/A Index: N/A
Free Cash Flow: -2919014.0 FCF Growth: N/A

AI-Powered NMTC Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 2 days ago

AI Recommendation

hold
Model Accuracy: 67.53%
67.53%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest NeuroOne Medical Technologies Corporation News

NMTC Breaking Stock News: Dive into NMTC Ticker-Specific Updates for Smart Investing

All NMTC News

Share on Social Networks: